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Objectives. We tested the hypothesis that ischemic myocardium
can be sensitively detected using tissue Doppler-derived myocar-
dial velocity gradient (MVG) by a dobutamine challenge.
Background. Although tissue Doppler imaging (TDI) has re-
cently emerged to quantify regional myocardial contraction, in-
creased translational motion during a dobutamine challenge may
affect the measurements. MVG is an indicator of regional myo-
cardial contraction independent of the translational motion.
Methods. We studied 19 patients with (n 5 13) and without
(n 5 6) confirmed single-vessel coronary artery disease. Left
ventricular short-axis tissue Doppler images were obtained along
with conventional echocardiograms during a submaximal two-
step dobutamine challenge (10 and 30 mg/kg body weight per min).
Endocardial velocity as well as MVG were derived from TDI using
computer analysis in the anteroseptal and posterior segments and
were compared with visual interpretation.
Results. MVG demonstrated a significant dose-responsive in-
crease in the nonischemic segments (anteroseptal: 2.6 6 0.8/s to
6.0 6 1.0/s [mean 6 SD], p < 0.05; posterior: 3.9 6 0.7/s to 7.6 6
1.8/s, p < 0.05) but remained unchanged in the ischemic segments
(anteroseptal: 2.5 6 0.8/s to 2.7 6 0.7/s, p 5 NS; posterior: 3.4 6
1.0/s to 4.1 6 0.9/s, p 5 NS). Endocardial velocity failed to clearly
demonstrate the differing responses between the nonischemic
(anteroseptal: 22.3 6 1.2 to 22.7 6 1.6 cm/s, p 5 NS; posterior:
3.8 6 1.1 to 7.3 6 2.7 cm/s, p < 0.05) and ischemic segments
(anteroseptal: 22.1 6 0.5 to 22.8 6 0.8 cm/s, p 5 NS; posterior:
4.2 6 0.8 to 6.5 6 2.6 cm/s, p 5 NS). Wall motion abnormality was
hardly detectable with visual interpretation (wall motion score
range 1.00 to 1.33).
Conclusions. Abnormal segments could be sensitively detected
by using MVG in a submaximal dobutamine challenge, even where
conventional methods failed to detect the abnormality.
(J Am Coll Cardiol 1998;31:89–93)
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The recent advent of a tissue Doppler imaging (TDI) tech-
nique has enabled tissue motion velocity measurements in real
time (1–8). However, because TDI detects the velocity against
the transducer, the translational motion of the heart affects the
velocity measurement (4). The effect of translation may be-
come particularly augmented when a high dose of dobutamine
is given.
The myocardial velocity gradient (MVG), derived from
two-dimensional TDI, is an indicator of regional left ventric-
ular contraction that has been proved to be independent of the
translational motion (9,10). However, the usefulness of MVG
in detecting ischemic myocardium during a dobutamine chal-
lenge remains to be determined. Thus, this study sought to 1)
assess the feasibility of MVG measurements during a dobut-
amine challenge to detect ischemic myocardium; and 2) com-
pare the usefulness of MVG with that of tissue Doppler-
derived endocardial velocity, along with visual interpretation in
patients with confirmed coronary artery disease.
Methods
Study subjects. We enrolled 26 consecutive patients re-
ferred to the catheterization laboratory for diagnostic coronary
arteriography. Exclusion criteria for the enrollment were 1)
multiple coronary artery disease, 2) previous myocardial in-
farction, 3) valvular or myocardial disease, 4) documented
coronary artery spasm, 5) nondominant right coronary artery
disease, and 6) atrial fibrillation. Six patients were subse-
quently excluded because of inadequate echocardiographic
images, and one was excluded because he refused a dobut-
amine challenge. Of the 19 patients studied (15 men, 4 women;
mean [6SD] age 60 6 9 years), 13 had angiographically
significant ($75% obstruction) single-vessel coronary artery
disease with exertional chest pain (left anterior descending
coronary artery in 7, dominant right coronary artery in 3, left
circumflex coronary artery in 3). Six had normal coronary
arteries with atypical chest pain, diagnosed as chest pain
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syndrome. Exercise thallium-201 single-photon emission com-
puted tomography was performed in all patients. Regional
myocardial ischemia due to the related coronary artery ob-
struction included either the anteroseptal or the posterior wall
of each patient who had significant coronary artery obstruc-
tion. All patients were in sinus rhythm, and informed consent
was obtained from all. Five patients had diabetes mellitus,
eight had hypertension, and three were taking oral beta-
adrenergic blocking agents.
Dobutamine challenge. A two-step submaximal dobut-
amine challenge was performed within 2 weeks of coronary
arteriography. Dobutamine was given intravenously through a
peripheral arm vein and was started at a dose of 10 mg/kg body
weight per min (low dose). After 3 min, tissue Doppler and
conventional echocardiographic images were recorded. On
completion of the recording, the dose was increased to
30 mg/kg per min (high dose). Three minutes after the increase
of the dose, the tissue Doppler and conventional echocardio-
graphic images were again recorded. The recording time for
each step was ;5 to 8 min.
The infusion of dobutamine was stopped before reaching
the high dose because of progressive severe angina, $2-mm ST
segment deviation, clinically significant arrhythmia, systolic
blood pressure .200 mm Hg or development of intolerable
symptoms, such as severe headache. Blood pressure and the
12-lead electrocardiogram (ECG) were monitored throughout
the challenge. Neither dipyridamole nor atropine was added
even if the dobutamine challenge was negative at the end of
the high dose. Visual interpretation of regional wall motion
was done using a four-point scale: 1 5 normal; 2 5 hypokine-
sia; 3 5 akinesia; 4 5 dyskinesia (11). Two expert sonogra-
phers who had performed and interpreted .200 dobutamine
stress echocardiograms had no knowledge of the other results
and interpreted the videotapes of the left ventricular short-axis
recordings. Both sonographers agreed with the interpretation.
TDI and MVG. TDI and MVG have been described in
detail elsewhere (2,4,9,10). In brief, we used an ultrasound
system capable of high frame rate (up to 57 Hz) two-
dimensional TDI (SSA-380A, Toshiba Corp.) with a 3.75-MHz
sector transducer. MVG was defined as the slope of the
regression line of the intramyocardial velocity profile across
the myocardial wall (9,12). If the intramyocardial velocity
profile can be approximated as linear, MVG is equivalent to
the difference in myocardial velocity between the endocardium
and epicardium normalized by the wall thickness. Hence,
MVG reflects the regional wall thickening (9).
Image acquisition and analysis. We used the parasternal
short-axis slice at the level of the papillary muscles. Conven-
tional two-dimensional echocardiograms were recorded on an
S-VHS videocassette. Tissue Doppler images were obtained by
setting the velocity dynamic range as low as possible to
maximize the velocity resolution while avoiding velocity satu-
ration during systole, as had been done in our previous studies
(9,10). By reviewing the color display of the cine loop, frames
that showed the highest velocity along the endocardium were
chosen for the anteroseptal and posterior segments in each
systole. A pair of images that comprised a conventional
two-dimensional echocardiographic image and a correspond-
ing tissue Doppler velocity image that was set specifically for
the computer analysis were simultaneously obtained and trans-
ferred to a personal computer (Macintosh 8100, Apple Com-
puter Inc.) through an RGB graphic interface (IG24, Neotec
Ltd.) using custom software.
Endocardial velocities in the anteroseptal and posterior
segments were also measured with the computer software by
depicting the velocities along the endocardium and averaged
from 3 consecutive beats.
For MVG measurements, we set the center of the left
ventricle in each short-axis echo frame and then traced the
endocardium and epicardium. Subsequently, velocity data
were automatically corrected by the actual Doppler angle of
incidence for each pixel, and the velocity profiles across the left
ventricular wall were obtained. MVG was calculated as the
slope of each velocity profile by using least squares linear
regression. Positive gradients, indicating thickening of the
myocardium, were encoded red, and negative gradients, indi-
cating thinning of the myocardium were encoded blue on
MVG images (Fig. 1). We measured the segmental MVG from
the anteroseptal (;45° around the 12 o’clock position) and
from the posterior (;45° around the 6 o’clock position)
segments for quantification. Each segmental MVG was aver-
aged from 3 consecutive beats.
Intraobserver and interobserver variability. Reproducibil-
ity of MVG measurements during the dobutamine challenge
was assessed in 10 randomly allocated segments. The mean
difference between the MVG measurements was 0.4 6 0.2/s.
Interobserver variability was also assessed in the same 10
segments by two independent observers (H.T., M.U.). The
mean difference between the measurements of the two observ-
ers was 0.9 6 0.5/s. Reproducibility of peak endocardial
velocity measurements was also assessed in the same 10
segments. Mean intraobserver difference in the endocardial
velocity measurements was 0.3 6 0.2 cm/s, and the mean
interobserver difference was 0.8 6 0.7 cm/s.
Statistical analysis. Results are expressed as mean value 6
SD. Two-way analysis of variance, followed by a Newman-
Keuls post hoc test, was performed for repeated measures; p ,
0.05 was considered statistically significant.
Results
Dobutamine challenge and visual interpretation. Fourteen
of the 19 patients completed the two-step protocol. Five
patients did not reach the high dose stage because of signifi-
Abbreviations and Acronyms
ECG 5 electrocardiogram, electrocardiographic
MVG 5 myocardial velocity gradient
TDI 5 tissue Doppler imaging
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cant ECG changes (n 5 2), severe systolic hypertension (n 5
1) or intolerable palpitation (n 5 2). Of these five patients,
three had no significant coronary artery obstruction and one
had anterior and one posterior myocardial ischemia. The
number of segments analyzed in each subgroup is shown in
Table 1. Only one patient developed chest pain, and three had
ECG changes indicative of myocardial ischemia. Heart rate
increased from 58 6 8 beats/min at rest to 93 6 24 beats/min
at peak stress. Systolic blood pressure rose from 122 6
16 mm Hg at rest to 160 6 29 mm Hg at peak stress.
Among all 104 segments studied, three were interpreted as
hypokinesia at rest. Worsening of the wall motion, from
normokinesia to hypokinesia, was detected in one patient
during the dobutamine challenge. In the other 15 patients, wall
motion was interpreted as normal throughout the test. The
mean point score ranged from 1.14 to 1.33 in the segments
related to significant coronary artery obstruction (ischemic
segments) and from 1.00 to 1.08 in the nonischemic segments
(Table 1). Overall, segmental abnormalities were barely de-
tectable with visual interpretation. No major complications
were encountered during the test.
Endocardial velocity. Peak endocardial velocity was nega-
tive in the anteroseptal segments, but was positive in the
posterior segments, reflecting the directional difference in wall
motion (Fig. 2). Endocardial velocity in the posterior segments
showed a tendency toward a dose-responsive increase during
the dobutamine challenge, not only in the nonischemic seg-
ments, but also in the ischemic segments, although statistical
significance was not reached except for nonischemic segments
at the high dose (Table 1). In contrast, endocardial velocity in
Figure 1. Standard TDI (top) and MVG (bottom)
images of the left ventricular short-axis slice at the
level of the papillary muscles during the two-step
submaximal dobutamine challenge in a patient with
left anterior descending coronary artery obstruction.
From left to right: before (control) and during low
(10 mg/kg per min) and high dose dobutamine
(30 mg/kg per min). The anteroseptal wall is color
coded blue and the posterior wall red, depending on
the direction of motion in the standard TDI images. In
the MVG images, thickening of the myocardium is
color coded red, and thinning of the myocardium blue.
Numbers denote segmental MVG (/s) derived from
the anteroseptal and the posterior segments. MVG in
the posterior segment revealed a dose-responsive in-
crease (from 4.5 to 8.0/s), whereas MVG remained
substantially unchanged in the anteroseptal segment
(from 2.9 to 3.4/s).
Table 1. Comparison of Mean Point Scores, Uncorrected Tissue Doppler Endocardial Velocities and
Myocardial Velocity Gradients Derived From Nonischemic and Ischemic Segments
Anteroseptal Segments Posterior Segments
Baseline
Dobutamine
Baseline
Dobutamine
10 mg/kg
per min
30 mg/kg
per min
10 mg/kg
per min
30 mg/kg
per min
Mean point score
Nonischemic 1.08 1.00 1.00 1.00 1.00 1.00
n 5 12 n 5 12 n 5 8 n 5 13 n 5 13 n 5 9
Ischemic 1.14 1.14 1.16 1.16 1.33 1.20
n 5 7 n 5 7 n 5 6 n 5 6 n 5 6 n 5 5
Endocardial velocity (cm/s)
Nonischemic 22.3 6 1.2 23.1 6 1.8 22.7 6 1.6 3.8 6 1.1 5.7 6 2.5 7.3 6 2.7*†
n 5 12 n 5 12 n 5 7 n 5 13 n 5 13 n 5 7
Ischemic 22.1 6 0.5 23.2 6 0.9 22.8 6 0.8 4.2 6 0.8 5.7 6 1.7 6.5 6 2.6
n 5 7 n 5 7 n 5 6 n 5 6 n 5 6 n 5 5
MVG (/s)
Nonischemic 2.6 6 0.8 4.6 6 1.2* 6.0 6 1.0*† 3.9 6 0.7 6.1 6 1.5* 7.6 6 1.8*†
n 5 10 n 5 10 n 5 5 n 5 13 n 5 13 n 5 8
Ischemic 2.5 6 0.8 3.1 6 0.7 2.7 6 0.7‡ 3.4 6 1.0 3.5 6 1.0‡ 4.1 6 0.9‡
n 5 7 n 5 7 n 5 6 n 5 6 n 5 6 n 5 5
*p , 0.05 versus baseline. †p , 0.05 versus 10 mg/kg per min. ‡p , 0.05 versus nonischemic segments. MVG 5
myocardial velocity gradient. Data presented are mean 6 SD or number of segments analyzed.
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the anteroseptal segments did not demonstrate a dose-
responsive increase during the test, even in the nonischemic
segments (Table 1). There was no statistical difference between
ischemic and nonischemic segments both in anteroseptal and
posterior segments with regard to endocardial velocity (Table 1).
MVG. MVG could be derived from 96 (92%) of 104
segments recorded. MVG in each nonischemic segment dem-
onstrated a dose-responsive increase, whereas MVG in each
ischemic segment remained substantially unchanged during
the dobutamine stress test (Fig. 3). Statistical significance
between the nonischemic and ischemic segments was reached
from the low dose stage in the posterior segments (Table 1).
Similar results were obtained regarding the anteroseptal seg-
ments, although the high dose of dobutamine was required for
statistical significance (Table 1). A significant increase in MVG
(.2.6/s increase at the high dose stage) was observed in each
nonischemic segment, whereas no ischemic segment showed an
increase in MVG .1.5/s (Fig. 4). Thus, by using MVG,
ischemic segments were distinguished from nonischemic seg-
ments, even with a submaximal dobutamine challenge, whereas
endocardial velocity failed to characterize ischemic and nonisch-
emic segments.
Discussion
TDI has recently been applied to the quantification of
dobutamine stress echocardiography (13,14). Although this
methodology is promising, several problems remain to be
solved. Among them are the effects of translational motion of
the heart, which cannot be neglected in certain clinical settings,
such as right ventricular volume overload (15–17) or after open
heart surgery (18,19). Translational motion is most likely
exaggerated when a high dose of dobutamine is given. In the
present study, although tissue Doppler endocardial velocity
tended to increase in nonischemic segments during the sub-
maximal dobutamine challenge, the difference in endocardial
velocity between ischemic and nonischemic segments did not
reach statistical significance. This result may be explained by
the exaggerated translational motion of the heart. The entire
heart shifts upward during systole; therefore, the endocardial
velocity in the posterior segment is detected as the sum of the
myocardial thickening and the translational velocities, whereas
in the anteroseptal segment, the endocardial velocity is de-
tected as the difference between the thickening and transla-
tional velocities. Hence, subtle changes in myocardial contrac-
tion may well be masked under exaggerated translational
motion.
In the present study, worsening of segmental wall motion
was only observed in one patient with conventional visual
interpretation, which may be explained by the submaximal
nature of the dobutamine challenge: 30 mg/kg per min of
dobutamine may not have been sufficient to induce significant
myocardial ischemia in the majority of our patients with
single-vessel coronary artery disease (20,21). It is also notewor-
thy that single-vessel coronary artery disease has been docu-
mented as difficult to diagnose with conventional interpreta-
tion, even if the standard dobutamine stress test is performed
(22–25). Enhanced adjacent segmental motion or an increase
in the translational motion, or both, may affect the interpreta-
tion in this disease entity.
Under these circumstances, MVG from the ischemic seg-
ments remained substantially unchanged during the dobut-
Figure 2. Alterations in the tissue Doppler endocardial velocity (cm/s)
derived from each segment during the dobutamine challenge. A,
Nonischemic anteroseptal segments. B, Ischemic anteroseptal seg-
ments. C, Nonischemic posterior segments. D, Ischemic posterior
segments.
Figure 3. Alterations in MVG (/s) derived from each segment during
the dobutamine challenge. A, Nonischemic anteroseptal segments. B,
Ischemic anteroseptal segments. C, Nonischemic posterior segments.
D, Ischemic posterior segments.
Figure 4. Increases in endocardial velocity (left) and in MVG (right)
at the high dose stage of the dobutamine challenge for ischemic versus
nonischemic myocardial segments. Endocardial velocity failed to dis-
tinguish between ischemic and nonischemic segments. In contrast, a
significant increase in MVG .2.6/s was observed in all nonischemic
segments, whereas no ischemic segment showed an increase in MVG
.1.5/s.
92 TSUTSUI ET AL. JACC Vol. 31, No. 1
TISSUE DOPPLER DETECTION OF ISCHEMIC MYOCARDIUM January 1998:89–93
amine infusion, although wall motion in these segments was
apparently observed to be augmented. In contrast, MVG
demonstrated a significant dose-responsive increase in all
nonischemic segments. Thus, MVG may be more sensitive in
detecting subtle wall motion changes than a point score
method or tissue Doppler endocardial velocity.
Clinical implications. Although the dobutamine stress test
is useful in its present form, its subjective interpretation
remains as an unsolved issue. By using MVG, quantitative and
objective assessment of wall motion may be possible in dobut-
amine stress echocardiography. In addition, the dose of dobut-
amine or atropine, or both, needed to detect ischemic myocar-
dium may be reduced by using MVG to detect the subtle changes
in wall motion. In fact, we detected the ischemic segments with a
submaximal dobutamine challenge using MVG, where conven-
tional methods failed to demonstrate the abnormality.
Limitations of the study. The small number of myocardial
segments and patients assessed in this study should be noted as
a limitation. Although assessment of multiple views is indis-
pensable in standard dobutamine stress echocardiography, we
could not perform standard dobutamine stress echocardiogra-
phy with multiple planes because of the prototypic off-line
nature of the MVG analysis system available. Nonetheless,
MVG has a potential advantage over the conventional meth-
ods because MVG could detect ischemic segments even in
patients with single-vessel coronary artery disease during sub-
maximal dobutamine challenge, where the conventional meth-
ods failed to demonstrate the abnormality. Further advance-
ments in engineering are awaited to facilitate a prospective
study that would include a large number and variety of patients
with the standard dobutamine protocol, including multiple
plane assessment.
Our study cohort included only patients undergoing coro-
nary arteriography, which might bias the “normal” cohort,
although we performed thallium scintigraphy to exclude pa-
tients with regional abnormalities in myocardial perfusion. In
this regard, a large-scale prospective study would be of partic-
ular interest once a real-time analysis system was available for
clinical use.
Conclusions. The present study demonstrates the compar-
ative usefulness and advantage of MVG over tissue Doppler
endocardial velocity, as well as conventional visual interpreta-
tion, in detecting ischemic myocardium during a submaximal
dobutamine challenge.
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